Thus, theoverexpression of EGFR in 95% of NF1 patients with MPNST and the very poorprognosis of these young patients shown in the present study suggest that newtherapies targeting EGFR might be interesting for these patients. This evidence concerns the gene EGFR and neurofibromatosis type 1.